Medication-Assisted Treatment (MAT) Treatment Centers

Medication-assisted treatment programs reduce opioid overdose deaths by 50% and all-cause mortality by more than 50%, according to SAMHSA. Santa Cruz Drug Rehab connects you with SAMHSA-certified MAT providers offering FDA-approved medications combined with evidence-based counseling for opioid and alcohol use disorders.

NIDA Endorses MAT as the Gold Standard

The National Institute on Drug Abuse (NIDA) endorses medication-assisted treatment programs as the gold standard for opioid use disorder. SAMHSA data confirms MAT reduces illicit opioid use, criminal activity, and infectious disease transmission while improving treatment retention, social functioning, and birth outcomes for pregnant women. Treatment retention rates vary by medication: methadone retains 50-70% of patients at one year, buprenorphine 40-60%, and injectable naltrexone 30-40%.

FDA-Approved MAT Medications for Opioid Use Disorder

Three FDA-approved medication classes target opioid use disorder through distinct mechanisms of action:

• Buprenorphine (Suboxone, Sublocade, Subutex): A partial opioid agonist that binds opioid receptors with a ceiling effect, reducing cravings and withdrawal symptoms without producing euphoria at prescribed doses. Available as sublingual film, tablet, or monthly Sublocade injection. Since the 2023 Consolidated Appropriations Act eliminated the X-waiver requirement, any DEA-licensed prescriber can now prescribe buprenorphine, greatly expanding access to medication-assisted treatment programs.
• Methadone (Dolophine): A full opioid agonist administered through SAMHSA-certified Opioid Treatment Programs (OTPs) under 42 CFR Part 8 regulations. Effective for severe opioid use disorder with the highest retention rates (50-70% at one year). Requires daily supervised dosing initially, with take-home privileges earned over time.
• Naltrexone (Vivitrol, ReVia): An opioid antagonist that completely blocks opioid receptors, preventing any euphoric effect. Available as oral ReVia (50mg daily) or extended-release Vivitrol injection (380mg intramuscularly monthly). Requires full opioid detoxification before initiation to avoid precipitated withdrawal.

FDA-Approved MAT Medications for Alcohol Use Disorder

Three FDA-approved medications treat alcohol use disorder through complementary pharmacological pathways:

• Naltrexone (oral 50mg daily or Vivitrol 380mg IM monthly): Blocks opioid receptors in the brain's reward pathway, reducing alcohol cravings and the reinforcing effects of drinking. The COMBINE Study demonstrated naltrexone's efficacy when paired with medical management.
• Acamprosate (Campral, 666mg three times daily): Restores balance to GABA and glutamate neurotransmitter systems disrupted by chronic alcohol use, reducing post-acute withdrawal symptoms like insomnia, anxiety, and dysphoria.
• Disulfiram (Antabuse, 250-500mg daily): Inhibits aldehyde dehydrogenase, causing an aversive reaction (nausea, flushing, headache) when alcohol is consumed. Most effective under supervised administration.

MAT Is Not "Replacing One Drug with Another"

A common misconception is that medication-assisted treatment programs substitute one addiction for another. In reality, MAT medications are carefully dosed to normalize brain chemistry, prevent withdrawal, and reduce cravings without producing intoxication. Patients on stable MAT regimens can function normally, maintain employment, care for families, and fully engage in therapy and recovery activities. All substance use disorder treatment records receive enhanced confidentiality protections under 42 CFR Part 2, which restricts disclosure beyond standard HIPAA requirements.

Comprehensive Medication-Assisted Treatment Programs

Medication alone is not sufficient. Santa Cruz Drug Rehab lists MAT providers that combine pharmacotherapy with cognitive behavioral therapy, motivational interviewing, peer support groups, and wraparound services including case management and vocational support. Browse our treatment center directory to find comprehensive medication-assisted treatment programs near you.